Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 601

1.

Lynch Syndrome: A Primer for Urologists and Panel Recommendations.

Mork M, Hubosky SG, Rouprêt M, Margulis V, Raman J, Lotan Y, O'Brien T, You N, Shariat SF, Matin SF.

J Urol. 2015 Feb 21. pii: S0022-5347(15)00391-2. doi: 10.1016/j.juro.2015.02.081. [Epub ahead of print] Review.

PMID:
25711197
2.

Genetic diagnosis of high-penetrance susceptibility for colorectal cancer (CRC) is achievable for a high proportion of familial CRC by exome sequencing.

Chubb D, Broderick P, Frampton M, Kinnersley B, Sherborne A, Penegar S, Lloyd A, Ma YP, Dobbins SE, Houlston RS.

J Clin Oncol. 2015 Feb 10;33(5):426-32. doi: 10.1200/JCO.2014.56.5689. Epub 2015 Jan 5.

PMID:
25559809
3.

Short-term risk of colorectal cancer in individuals with lynch syndrome: a meta-analysis.

Jenkins MA, Dowty JG, Ait Ouakrim D, Mathews JD, Hopper JL, Drouet Y, Lasset C, Bonadona V, Win AK.

J Clin Oncol. 2015 Feb 1;33(4):326-31. doi: 10.1200/JCO.2014.55.8536. Epub 2014 Dec 22.

PMID:
25534380
4.

Muir-Torre syndrome.

Bhaijee F, Brown AS.

Arch Pathol Lab Med. 2014 Dec;138(12):1685-9. doi: 10.5858/arpa.2013-0301-RS. Review.

PMID:
25427047
5.

Comparison of clinical features between suspected familial colorectal cancer type X and Lynch syndrome in Japanese patients with colorectal cancer: a cross-sectional study conducted by the Japanese Society for Cancer of the Colon and Rectum.

Yamaguchi T, Furukawa Y, Nakamura Y, Matsubara N, Ishikawa H, Arai M, Tomita N, Tamura K, Sugano K, Ishioka C, Yoshida T, Moriya Y, Ishida H, Watanabe T, Sugihara K; HNPCC Registry and Genetic Testing Project of the Japanese Society for Cancer of the Colon and Rectum.

Jpn J Clin Oncol. 2015 Feb;45(2):153-9. doi: 10.1093/jjco/hyu190. Epub 2014 Nov 17.

PMID:
25404568
6.

Lynch syndrome screening should be considered for all patients with newly diagnosed endometrial cancer.

Mills AM, Liou S, Ford JM, Berek JS, Pai RK, Longacre TA.

Am J Surg Pathol. 2014 Nov;38(11):1501-9. doi: 10.1097/PAS.0000000000000321.

7.

Lynch Syndrome in patients with clear cell and endometrioid cancers of the ovary.

Vierkoetter KR, Ayabe AR, VanDrunen M, Ahn HJ, Shimizu DM, Terada KY.

Gynecol Oncol. 2014 Oct;135(1):81-4. doi: 10.1016/j.ygyno.2014.07.100. Epub 2014 Aug 2.

PMID:
25093288
8.

Temozolomide increases the number of mismatch repair-deficient intestinal crypts and accelerates tumorigenesis in a mouse model of Lynch syndrome.

Wojciechowicz K, Cantelli E, Van Gerwen B, Plug M, Van Der Wal A, Delzenne-Goette E, Song JY, De Vries S, Dekker M, Te Riele H.

Gastroenterology. 2014 Nov;147(5):1064-72.e5. doi: 10.1053/j.gastro.2014.07.052. Epub 2014 Jul 31.

PMID:
25088490
9.

BRAF mutation analysis is a valid tool to implement in Lynch syndrome diagnosis in patients classified according to the Bethesda guidelines.

Molinari F, Signoroni S, Lampis A, Bertan C, Perrone F, Sala P, Mondini P, Crippa S, Bertario L, Frattini M.

Tumori. 2014 May-Jun;100(3):315-20. doi: 10.1700/1578.17214.

PMID:
25076244
10.

Rare mutations in RINT1 predispose carriers to breast and Lynch syndrome-spectrum cancers.

Park DJ, Tao K, Le Calvez-Kelm F, Nguyen-Dumont T, Robinot N, Hammet F, Odefrey F, Tsimiklis H, Teo ZL, Thingholm LB, Young EL, Voegele C, Lonie A, Pope BJ, Roane TC, Bell R, Hu H, Shankaracharya, Huff CD, Ellis J, Li J, Makunin IV, John EM, Andrulis IL, Terry MB, Daly M, Buys SS, Snyder C, Lynch HT, Devilee P, Giles GG, Hopper JL, Feng BJ, Lesueur F, Tavtigian SV, Southey MC, Goldgar DE.

Cancer Discov. 2014 Jul;4(7):804-15. doi: 10.1158/2159-8290.CD-14-0212. Epub 2014 May 2.

11.

Germline mutation of RPS20, encoding a ribosomal protein, causes predisposition to hereditary nonpolyposis colorectal carcinoma without DNA mismatch repair deficiency.

Nieminen TT, O'Donohue MF, Wu Y, Lohi H, Scherer SW, Paterson AD, Ellonen P, Abdel-Rahman WM, Valo S, Mecklin JP, Järvinen HJ, Gleizes PE, Peltomäki P.

Gastroenterology. 2014 Sep;147(3):595-598.e5. doi: 10.1053/j.gastro.2014.06.009. Epub 2014 Jun 15.

12.

Risk of secondary malignancy (including breast) in patients with mismatch-repair protein deficiency.

Clay MR, Allison KH, Folkins AK, Longacre TA.

Am J Surg Pathol. 2014 Nov;38(11):1494-500. doi: 10.1097/PAS.0000000000000259.

PMID:
24921635
13.

Familial pancreatic cancer: challenging diagnostic approach and therapeutic management.

Mastoraki A, Chatzimavridou-Grigoriadou V, Chatzipetrou V, Mastoraki S, Papanikolaou IS, Danias N, Smyrniotis V, Arkadopoulos N.

J Gastrointest Cancer. 2014 Sep;45(3):256-61. doi: 10.1007/s12029-014-9609-8. Review.

PMID:
24756831
14.

Immunohistochemical expression pattern of MMR protein can specifically identify patients with colorectal cancer microsatellite instability.

Amira AT, Mouna T, Ahlem B, Raoudha A, Majid BH, Amel H, Rachida Z, Nadia K.

Tumour Biol. 2014 Jul;35(7):6283-91. doi: 10.1007/s13277-014-1831-2. Epub 2014 Mar 19.

PMID:
24643686
15.

New genes emerging for colorectal cancer predisposition.

Esteban-Jurado C, Garre P, Vila M, Lozano JJ, Pristoupilova A, Beltrán S, Abulí A, Muñoz J, Balaguer F, Ocaña T, Castells A, Piqué JM, Carracedo A, Ruiz-Ponte C, Bessa X, Andreu M, Bujanda L, Caldés T, Castellví-Bel S.

World J Gastroenterol. 2014 Feb 28;20(8):1961-71. doi: 10.3748/wjg.v20.i8.1961. Review.

16.

Association of tumor morphology with mismatch-repair protein status in older endometrial cancer patients: implications for universal versus selective screening strategies for Lynch syndrome.

Rabban JT, Calkins SM, Karnezis AN, Grenert JP, Blanco A, Crawford B, Chen LM.

Am J Surg Pathol. 2014 Jun;38(6):793-800. doi: 10.1097/PAS.0000000000000177.

PMID:
24503759
17.

Longer telomeres are associated with cancer risk in MMR-proficient hereditary non-polyposis colorectal cancer.

Seguí N, Guinó E, Pineda M, Navarro M, Bellido F, Lázaro C, Blanco I, Moreno V, Capellá G, Valle L.

PLoS One. 2014 Feb 3;9(2):e86063. doi: 10.1371/journal.pone.0086063. eCollection 2014.

18.

Evaluating the performance of clinical criteria for predicting mismatch repair gene mutations in Lynch syndrome: a comprehensive analysis of 3,671 families.

Steinke V, Holzapfel S, Loeffler M, Holinski-Feder E, Morak M, Schackert HK, Görgens H, Pox C, Royer-Pokora B, von Knebel-Doeberitz M, Büttner R, Propping P, Engel C; German HNPCC Consortium.

Int J Cancer. 2014 Jul 1;135(1):69-77. doi: 10.1002/ijc.28650. Epub 2014 Feb 20.

PMID:
24493211
19.

Muir-Torre syndrome: case report and molecular characterization.

Rios CA, Villalón R, Muñoz J, Acuña M, Cifuentes L.

Sao Paulo Med J. 2014;132(1):61-4. doi: 10.1590/1516-3180.2014.1321634.

20.

Evaluation of the colorectal cancer risk conferred by rare UNC5C alleles.

Küry S, Garrec C, Airaud F, Breheret F, Guibert V, Frenard C, Jiao S, Bonneau D, Berthet P, Bossard C, Ingster O, Cauchin E, Bezieau S.

World J Gastroenterol. 2014 Jan 7;20(1):204-13. doi: 10.3748/wjg.v20.i1.204.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk